Bide Pharmatech Co. Ltd. logo

Bide Pharmatech Co. Ltd. (688073)

Market Closed
11 Aug, 06:57
SSE SSE
¥
75. 41
+1.49
+2.0157%
¥
5.53B Market Cap
- P/E Ratio
3.6% Div Yield
9.99M Volume
- Eps
¥ 73.92
Previous Close
Add Transaction
Day Range
70.26 78.7
Year Range
43.21 82.88
Want to track 688073 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688073 closed today higher at ¥75.41, an increase of 2.0157% from yesterday's close, completing a monthly increase of 40.1152% or ¥21.59. Over the past 12 months, 688073 stock gained 22.1412%.
688073 is not paying dividends to its shareholders.
The last earnings report, released on Apr 25, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Bide Pharmatech Co. Ltd. has completed 1 stock splits, with the recent split occurring on May 25, 2023.
The company's stock is traded on one exchange.

688073 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Bide Pharmatech Co. Ltd. (688073) FAQ

What is the stock price today?

The current price is ¥75.41.

On which exchange is it traded?

Bide Pharmatech Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688073.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.6%.

What is its market cap?

As of today, the market cap is 5.53B.

Has Bide Pharmatech Co. Ltd. ever had a stock split?

Bide Pharmatech Co. Ltd. had 1 splits and the recent split was on May 25, 2023.

Bide Pharmatech Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Lan Dai CEO
SSE Exchange
CNE100005NV3 ISIN
CN Country
846 Employees
10 Jun 2026 Last Dividend
25 May 2023 Last Split
- IPO Date

Overview

Bide Pharmatech Co., Ltd., founded in 2007 and headquartered in Shanghai, China, is a dynamic entity that is involved in the research, development, production, and sale of pharmaceutical products. With a focus on contributing significantly to the realms of life sciences, organic chemistry, materials science, and analytical chemistry, the company has established itself as a noteworthy player in the Chinese pharmaceutical industry. The expertise and commitment to innovation have positioned Bide Pharmatech as a trusted partner for various stakeholders in the pharmaceutical and related sectors.

Products and Services

  • Life Sciences:

    Development and distribution of pharmaceuticals and solutions aimed at advancing life sciences research. These products facilitate the study of biological processes and diseases, with the goal of discovering and developing new therapies.

  • Organic Chemistry:

    Provision of a comprehensive array of chemicals and reagents critical for organic synthesis, including building blocks, reagents, and catalysts for researchers in academia and industry engaged in chemical synthesis and drug discovery.

  • Materials Science:

    Supply of high-quality materials science products that support the development and testing of novel materials. This includes the production of chemicals and compounds used in the creation of new materials with unique properties for various applications.

  • Analytical Chemistry:

    Offering an extensive portfolio of products for analytical chemistry applications, Bide Pharmatech aids in the precise measurement and analysis of chemical substances. These products are crucial for quality control, regulatory compliance, and research and development in both the pharmaceutical and chemical industries.

Contact Information

Address: Building 1, Shanghai, China, 200433
Phone: 86 21 6162 9020